نتایج جستجو برای: tenofovir disproxil fumarate

تعداد نتایج: 10210  

Journal: :Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512) 2019

2016
Nicholas T. Funderburg Grace A. McComsey Manjusha Kulkarni Tammy Bannerman Jessica Mantini Bernadette Thornton Hui C. Liu Yafeng Zhang Qinghua Song Liang Fang Jason Dinoso Andrew Cheng Scott McCallister Marshall W. Fordyce Moupali Das

BACKGROUND Initiation of antiretroviral therapy (ART) and subsequent virologic suppression reduces immune activation and systemic inflammation. METHODS We examined longitudinal changes in biomarkers of monocyte activation (sCD14, sCD163), and systemic (IL-6, hsCRP, sTNFR-I and D-dimer) and vascular (Lp-PLA2) inflammation in a subgroup (N=100 per arm) of participants enrolled in a randomized, ...

Journal: :PharmacoEconomics 2011
Helen Dakin Morris Sherman Scott Fung Carrie Fidler Anthony Bentley

INTRODUCTION Previous research has demonstrated that tenofovir disoproxil fumarate (DF) is the most cost-effective nucleos(t)ide treatment for chronic hepatitis B (CHB) in the UK, Spain, Italy and France. However, to our knowledge, no published studies have yet evaluated the cost effectiveness of any treatments for CHB in a Canadian setting, where relative prices and management of CHB differ fr...

Journal: :JAMA 2004
Joel E Gallant Schlomo Staszewski Anton L Pozniak Edwin DeJesus Jamal M A H Suleiman Michael D Miller Dion F Coakley Biao Lu John J Toole Andrew K Cheng

CONTEXT Tenofovir disoproxil fumarate (DF) is a once-daily nucleotide analogue reverse transcriptase inhibitor. OBJECTIVE To evaluate the efficacy and safety of tenofovir DF compared with stavudine in antiretroviral-naive patients. DESIGN, SETTING, AND PARTICIPANTS A prospective, randomized, double-blind study conducted at 81 centers in the United States, South America, and Europe from June...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید